Model N and Pharmaceutical Executive to Present Webcast on Using Analytics to Drive Agile Brand Management

Pharma Practitioners to Discuss How to Build the Capabilities that Lead to Optimal Brand Performance

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Redwood Shores, CA (PRWEB) October 12, 2012

Model N, the leader in Revenue Management solutions, is partnering with Pharmaceutical Executive to present “The Path to Agile Brand Management," a live webcast on October 25, 2012 at 2 p.m. EDT.

The pharmaceutical sales and marketing landscape is undergoing a significant transformation, requiring a new approach to achieving brand revenue goals. Today’s ultra-competitive environment requires speed and agility from both Sales and Marketing executives. David Stasior, M.D., Vice President and Chief Evangelist, Analytics at Model N and Jason Jones, Senior Director of Sales Operations and Insights at Covidien, will discuss key areas where a shared understanding of brand performance across Sales and Marketing can lead to agile decision making and consistent achievement of brand performance objectives.

Key Discussion Areas:

  •     Defining agile brand management and how it creates a competitive advantage
  •     Why a shared understanding across Sales and Marketing fosters agility
  •     How to enable agile brand management in a pharmaceutical company


Social Media Links

Follow Model N on Twitter
Follow Model N Linked In

About Model N

Model N, the leader in Revenue Management solutions, drives improved pricing, margin, and revenue performance through a powerful combination of best practices, highly configurable software applications, comprehensive services, and actionable analytics across the complete functional spectrum of pricing, contracting, rebating, sales, and marketing. Model N leverages its deep industry expertise to support the unique business needs of Life Sciences and High Tech manufacturers across more than 50 countries. Global Customers include: Allergan, Amgen, Atmel, Boston Scientific, Bristol-Myers Squibb, Dell, Hospira, Johnson & Johnson, Linear Technology, Merck, Marvell, Maxim, Micron, Nokia, Novartis, Novo Nordisk, ON Semiconductor, STMicroelectronics, and Watson Pharmaceuticals. Whether you are an emerging business or a global leader, Model N results in revenue.

Model N is a trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.